tiprankstipranks
Trending News
More News >

Atreca downgraded to Hold from Buy at Stifel

Stifel downgraded Atreca to Hold from Buy with a price target of $1, down from $4, following management’s decision to suspend further ATRC-101 clinical development and implement a 40% workforce reduction in attempt to preserve existing capital. While the firm believes the platform and the expanding library of deconvoluted targets “command intrinsic value,” the firm finds it “too challenging here” to construct a confident investment thesis on the prospects of those business development activities now required to bridge the P&L to longer-term sustainability, the analyst tells investors.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on BCEL:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue